Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment

Summary by Helena Independent Record
SHANGHAI, NANJING, China and PLEASANTON, Calif., Sept. 18, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies, today announced that the 36-month long-term follow-up data from the…

41 Articles

ABC FOX MontanaABC FOX Montana
+39 Reposted by 39 other sources
Center

2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment

SHANGHAI, NANJING, China and PLEASANTON, Calif., Sept. 18, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies, today announced that the 36-month long-term follow-up data from the…

·Missoula, United States
Read Full Article
GeneOnline NewsGeneOnline News

IASO Biotherapeutics Reports Three-Year Data on Fucaso CAR-T Therapy for Multiple Myeloma at 2025 IMS Meeting

IASO Biotherapeutics has released three-year follow-up […]

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 90% of the sources are Center
90% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Helena Independent Record broke the news in Helena, United States on Friday, September 19, 2025.
Sources are mostly out of (0)

Similar News Topics

Shanghai, China icon

Shanghai, China

News
For You
SearchBlindspotLocal